Skip to main content
Premium Trial:

Request an Annual Quote

Praise for Proteomics

The method of the year for 2012 is targeted proteomics, says Methagora, Nature Methods' blog. "Targeted proteomics … offers a tantalizing opportunity to bring a sampling of the power of mass spectrometry to the wider community of biologists," writes Daniel Evanko there. "The assays are simpler, easier to run and well suited to the hypothesis-driven experiments that are the mainstay of biological research."

Evanko notes that proteomic techniques have been around in smaller-scale versions, like as Western blots or immunofluorescence, and targeted mass spectrometry "offers the possibility for thousands of labs to move away from, or supplement, Western blots; and improve the quality and quantity of their protein measurements."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more